Daiichi Sankyo Prasugrel - 搜索图片

1022×1004
logosandbrands.directory
Daiichi Sankyo « Logos & Brands Directory
1571×1412
daiichisankyo.us
Oncology - Daiichi Sankyo US
480×360
clinicaltrialsarena.com
Prasugrel, Investigational Antiplatelet Agent by Daiichi Sankyo and ...
4078×734
getchecked.eu
Unterstützer - Get Checked!

770×500
drugdiscoverytrends.com
Daiichi Sankyo’s valemetostat fares well in lymphoma and leukemia study ...
2000×1333
bloomberg.com
Daiichi Sankyo Positions Its Covid Vaccine as a Booster in Japan ...
500×480
clinicaltrialsarena.com
Prasugrel, Investigational Antiplatelet Agent by Daiich…
800×600
pharmaceutical-technology.com
Daiichi Sankyo to develop Covid-19 vaccine candidate in Japan ...

2000×1333
ydesign.hk
Daiichi Sankyo
800×600
at.linkedin.com
Daiichi Sankyo, Inc. auf LinkedIn: #interns #pharma
320×226
slideshare.net
Dr. Hager 2012 interview Daiichi Sankyo Co. Ltd. | PPT
1280×720
clinicaltrialsarena.com
Daiichi Sankyo begins oncology therapy trial for metastatic tumours

2560×1707
ydesign.hk
Daiichi Sankyo
800×450
linkedin.com
Daiichi Sankyo on LinkedIn: #daiichisankyo #onedaiichisankyo
815×500
BioSpace
Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update | BioSpace
600×300
fiercepharma.com
Daiichi Sankyo tipped to dominate antibody-drug conjugate market ...

2560×1707
ydesign.hk
Daiichi Sankyo
800×366
liquidarea.com
E' arrivato Prasugrel, l'antiaggregante di nuova generazione contro la ...
1024×683
LinkedIn
Daiichi Sankyo, Inc. | LinkedIn
2560×1707
ydesign.hk
Daiichi Sankyo

1581×1186
shawcontract.com
Daiichi Sankyo Project Photography | ShawContract
800×450
linkedin.com
Daiichi Sankyo, Inc. on LinkedIn: #rarediseaseday
1200×800
reuters.com
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in boost…
320×180
slideshare.net
Role of Prasugrel | PPT

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果